Lisata Therapeutics files initial beneficial ownership statement for director Jeffrey S. Farrow
LSTA•Director Jeffrey S. Farrow filed an initial beneficial ownership statement for an event dated October 13, 2026.
1. Ownership filing
Lisata Therapeutics director Jeffrey S. Farrow filed an initial beneficial ownership statement for an event dated October 13, 2026.
